Abiocenter (Beijing) Biotechnology Co., Ltd.
We are a leading CRO biotech company. We focus on antibody development.
Penghui Xie
CEOAsieris Pharmaceuticals
Focused in genitourinary(GU)/women health field with 2 global assets for bladder cancer and pre-cervical cancer treatment in phase 3 stages,looking for in/out-licensing partnership in GU/women health area
Dandan Xie
BD DirectorAvancPharma
Avanc Pharmaceutical Co., Ltd (Avanc Pharma or the Company), a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, focuses on innovative drug R&D, production and distribution and has a long-term commitment to nervous system, oncology, perioperative drugs and pediatric drugs.
Hayden Gu
BD managerBayer
Top tier Pharmaceutical company in China with leading position in cardiovascular, diabetes, women healthcare, oncology.
Betty Huang
Head of BD China/APBeijing ATMbiomaterials Co., Ltd
DENTAL MATERIALS
STENTS
EPIDEMIC PREVENTION PRODUCTS ETC.
STENTS
EPIDEMIC PREVENTION PRODUCTS ETC.
grace wang
MDChengdu Brilliant Pharmaceutical Co., Ltd.
Brilliant was founded in Chengdu city in 2007, specializes in the manufacturing and sale of generic medicines, innovative biologicals, small molecules and inhaled preparations. The sales revenue in 2019 was nearly US $550 million. We have 5 R&D centers and 5 GMP factories.
Yanping Zhang
BDChina Meheco Group Co.Ltd
China Meheco Group Co., Ltd. (China Meheco), established in 1984, head office in Beijing. State-owned company listed at Shanghai Stock Exchange (No 600056).
The whole industry chain includes R&D, cultivation & processing, manufacturing, distribution, logistics, international trading, academic promotion, technical service etc.
The company has established a comprehensive business framework supported by pharmaceutical manufacture. The 12 drug plants of the Group system China Meheco are located in different regions in China. All production lines are proved by GMP, Good Manufacturing Practice, etc.
The whole industry chain includes R&D, cultivation & processing, manufacturing, distribution, logistics, international trading, academic promotion, technical service etc.
The company has established a comprehensive business framework supported by pharmaceutical manufacture. The 12 drug plants of the Group system China Meheco are located in different regions in China. All production lines are proved by GMP, Good Manufacturing Practice, etc.
Libin Zhao
BD DirectorChina Resources Sanjiu
A listed and famous Chinese pharmaceutical company and also the main profit center of CR pharmaceutical Group which is the 2nd largest pharmaceutical group in China. The company has rich experiences in collaboration with multinational companies such as Sanofi, Takeda, Roche, Bailey and Novo Nordisk and so on. We are looking forward to cooperating with partners whose assets could meet the unmet medical needs and whom desire to explore China market.
Vincent Liao
Senior Investment and BD managerConsulate General of Canada in Shanghai
For more than 120 years, the Trade Commissioner Service (TCS) has been helping Canadian companies navigate international markets. Our trade commissioners in more than 160 cities worldwide can provide you with key business insights and access to an unbeatable network of international contacts. The TCS provides Canadian businesses and organizations with tailored advice to help them enter new markets outside of Canada.